{"transactions":[{"id":969824,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71585,"kind":"person","name":"Giordano Natasha","position":1,"cik":"0001315585","reported_name":"Giordano Natasha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2025-12-15T21:49:15.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."}],"balance_after":125000,"derivative":{"exercise_price":0.93,"exercise_date":"2025-12-11","expiration_date":"2035-12-11","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001315585-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000131558525000003/primary_doc.xml","form_type":"4"}},{"id":969823,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":71585,"kind":"person","name":"Giordano Natasha","position":1,"cik":"0001315585","reported_name":"Giordano Natasha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2025-12-15T21:49:15.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":38320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an initial equity award upon appointment to the Company's board of directors (the \"Board\") of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately. The option exercise price is the Company's closing price on the date immediately prior to the reporting person's appointment to the Company's Board. The Board granted the options on December 11, 2025."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an initial equity award upon appointment to the Company's board of directors (the \"Board\") of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately. The option exercise price is the Company's closing price on the date immediately prior to the reporting person's appointment to the Company's Board. The Board granted the options on December 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an initial equity award upon appointment to the Company's board of directors (the \"Board\") of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately. The option exercise price is the Company's closing price on the date immediately prior to the reporting person's appointment to the Company's Board. The Board granted the options on December 11, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an initial equity award upon appointment to the Company's board of directors (the \"Board\") of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately. The option exercise price is the Company's closing price on the date immediately prior to the reporting person's appointment to the Company's Board. The Board granted the options on December 11, 2025."}],"balance_after":38320,"derivative":{"exercise_price":1.03,"exercise_date":"2025-12-11","expiration_date":"2035-12-11","underlying":"Common Stock","underlying_shares":38320},"source":{"system":"sec-edgar","filing":"0001315585-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000131558525000003/primary_doc.xml","form_type":"4"}},{"id":1749485,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":71585,"kind":"person","name":"Giordano Natasha","position":1,"cik":"0001315585","reported_name":"Giordano Natasha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-11-03T16:49:41.000Z","date":"2023-11-01","kind":"grant","planned":false,"acquired":true,"shares":437244,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on November 1, 2023. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":437244,"derivative":{"exercise_price":0.2088,"expiration_date":"2033-11-01","underlying":"Common Stock","underlying_shares":437244},"source":{"system":"sec-edgar","filing":"0001493152-23-039340","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1315585/000149315223039340/ownership.xml","form_type":"4"}},{"id":2114297,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":71585,"kind":"person","name":"Giordano Natasha","position":1,"cik":"0001315585","reported_name":"Giordano Natasha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-11-16T21:36:48.000Z","date":"2022-11-14","kind":"grant","acquired":true,"shares":142657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on November 14, 2022. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":142657,"derivative":{"exercise_price":0.7268,"expiration_date":"2032-11-14","underlying":"Common Stock","underlying_shares":142657},"source":{"system":"sec-edgar","filing":"0001493152-22-032695","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1315585/000149315222032695/ownership.xml","form_type":"4"}},{"id":2330725,"issuer":{"id":129056,"kind":"organization","name":"PLx Pharma Inc.","symbol":"PLXP"},"owners":[{"id":71585,"kind":"person","name":"Giordano Natasha","position":1,"cik":"0001315585","reported_name":"Giordano Natasha","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-16T08:35:24.000Z","date":"2022-03-15","kind":"purchase","acquired":true,"shares":4100,"price":3.6529,"value":14976.89,"ownership":{"direct":true},"balance_after":5186,"source":{"system":"sec-edgar","filing":"0000921895-22-000885","document":"form411577gio_03162022.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497504/000092189522000885/form411577gio_03162022.xml","form_type":"4"}},{"id":2374722,"issuer":{"id":129056,"kind":"organization","name":"PLx Pharma Inc.","symbol":"PLXP"},"owners":[{"id":71585,"kind":"person","name":"Giordano Natasha","position":1,"cik":"0001315585","reported_name":"Giordano Natasha","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-24T20:13:41.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of stock options to the Reporting Person under the Issuer's 2018 Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest over a three year period as follows: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary of the grant date and 1/3 on the third anniversary of the grant date."}],"balance_after":300000,"derivative":{"exercise_price":4.99,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000921895-22-000661","document":"form411577gio_02242022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497504/000092189522000661/form411577gio_02242022.xml","form_type":"4"}},{"id":2528381,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":71585,"kind":"person","name":"Giordano Natasha","position":1,"cik":"0001315585","reported_name":"Giordano Natasha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-11-02T16:22:58.000Z","date":"2021-11-01","kind":"grant","acquired":true,"shares":90882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2021. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":90882,"derivative":{"exercise_price":1.12,"expiration_date":"2031-11-01","underlying":"Common Stock","underlying_shares":90882},"source":{"system":"sec-edgar","filing":"0001493152-21-026993","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1315585/000149315221026993/ownership.xml","form_type":"4"}},{"id":2606824,"issuer":{"id":129056,"kind":"organization","name":"PLx Pharma Inc.","symbol":"PLXP"},"owners":[{"id":71585,"kind":"person","name":"Giordano Natasha","position":1,"cik":"0001315585","reported_name":"Giordano Natasha","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-11T09:01:17.000Z","date":"2021-08-09","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of stock options to the Reporting Person under the Issuer's 2018 Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest over a three year period as follows: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary of the grant date and 1/3 on the third anniversary of the grant date."}],"balance_after":200000,"derivative":{"exercise_price":16.97,"expiration_date":"2031-08-09","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000921895-21-001976","document":"form411577002gio_08112021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497504/000092189521001976/form411577002gio_08112021.xml","form_type":"4"}},{"id":2971264,"issuer":{"id":129056,"kind":"organization","name":"PLx Pharma Inc.","symbol":"PLXP"},"owners":[{"id":71585,"kind":"person","name":"Giordano Natasha","position":1,"cik":"0001315585","reported_name":"Giordano Natasha","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T19:39:39.000Z","date":"2020-11-18","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of stock options to the Reporting Person under the Issuer's 2018 Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest over a three year period as follows: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary of the grant date and 1/3 on the third anniversary of the grant date."}],"balance_after":350000,"derivative":{"exercise_price":5.15,"expiration_date":"2030-11-18","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0000921895-20-003081","document":"form411577002gio_11202020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497504/000092189520003081/form411577002gio_11202020.xml","form_type":"4"}},{"id":3196464,"issuer":{"id":129056,"kind":"organization","name":"PLx Pharma Inc.","symbol":"PLXP"},"owners":[{"id":71585,"kind":"person","name":"Giordano Natasha","position":1,"cik":"0001315585","reported_name":"Giordano Natasha","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-03-24T20:52:07.000Z","date":"2020-03-20","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of stock options to the Reporting Person under the Issuer's 2018 Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest over a three year period as follows: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary of the grant date and 1/3 on the third anniversary of the grant date."}],"balance_after":175000,"derivative":{"exercise_price":2.16,"expiration_date":"2030-03-20","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0000921895-20-000903","document":"form411577002gio_03242020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497504/000092189520000903/form411577002gio_03242020.xml","form_type":"4"}},{"id":3400265,"issuer":{"id":154617,"kind":"organization","name":"ACETO CORP","symbol":"ACETQ"},"owners":[{"id":71585,"kind":"person","name":"Giordano Natasha","position":1,"cik":"0001315585","reported_name":"Giordano Natasha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2019-10-03T18:12:05.000Z","date":"2019-10-01","kind":"other","acquired":false,"shares":20972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 19, 2019, the Issuer and certain of its U.S. subsidiaries (collectively, the \"Debtors\") each filed voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of New Jersey (the \"Bankruptcy Court\"). On September 18, 2019, the Issuer's Second Modified Joint Plan of Liquidation of Aceto Corporation and Its Affiliated Debtors (as amended and supplemented, the \"Plan\") was confirmed by the Bankruptcy Court. As of October 1, 2019 at 12:01 a.m. (Eastern Standard Time), all applicable conditions set forth in the Plan were satisfied or waived and the effective date of the Plan occurred (the \"Effective Date\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to the Plan, all existing equity interests were cancelled on the Effective Date; provided that one share of the Issuer's common stock was issued and transferred to the Plan Administrator (as defined in the Plan) for purposes of administering the wind-down of the Issuer. Accordingly, this Form 4 shall constitute an exit filing for the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Plan, all existing equity interests were cancelled on the Effective Date; provided that one share of the Issuer's common stock was issued and transferred to the Plan Administrator (as defined in the Plan) for purposes of administering the wind-down of the Issuer. Accordingly, this Form 4 shall constitute an exit filing for the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Pursuant to the Plan, all existing equity interests were cancelled on the Effective Date; provided that one share of the Issuer's common stock was issued and transferred to the Plan Administrator (as defined in the Plan) for purposes of administering the wind-down of the Issuer. Accordingly, this Form 4 shall constitute an exit filing for the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905718-19-000842","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034/000090571819000842/ownership.xml","form_type":"4"}},{"id":3590563,"issuer":{"id":129056,"kind":"organization","name":"PLx Pharma Inc.","symbol":"PLXP"},"owners":[{"id":71585,"kind":"person","name":"Giordano Natasha","position":1,"cik":"0001315585","reported_name":"Giordano Natasha","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2019-03-18T21:09:03.000Z","date":"2019-03-14","kind":"grant","acquired":true,"shares":211675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of stock options to the Reporting Person under the Issuer's 2018 Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest over a three year period as follows: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary of the grant date and 1/3 on the third anniversary of the grant date."}],"balance_after":211675,"derivative":{"exercise_price":5.79,"expiration_date":"2029-03-14","underlying":"Common Stock","underlying_shares":211675},"source":{"system":"sec-edgar","filing":"0000921895-19-000815","document":"form411577gio_03182019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497504/000092189519000815/form411577gio_03182019.xml","form_type":"4"}},{"id":4137601,"issuer":{"id":154617,"kind":"organization","name":"ACETO CORP","symbol":"ACETQ"},"owners":[{"id":71585,"kind":"person","name":"Giordano Natasha","position":1,"cik":"0001315585","reported_name":"Giordano Natasha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2017-12-11T13:47:52.000Z","date":"2017-12-07","kind":"grant","acquired":true,"shares":6737,"price":10.39,"value":69997.43,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock pursuant to long term incentive plan; vests 100% after 13 months."}],"balance_after":20972,"source":{"system":"sec-edgar","filing":"0001140361-17-045644","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034/000114036117045644/doc1.xml","form_type":"4"}},{"id":4235317,"issuer":{"id":129056,"kind":"organization","name":"PLx Pharma Inc.","symbol":"PLXP"},"owners":[{"id":71585,"kind":"person","name":"Giordano Natasha","position":1,"cik":"0001315585","reported_name":"Giordano Natasha","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-08-14T17:12:46.000Z","date":"2017-08-11","kind":"grant","acquired":true,"shares":86872,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":86872,"derivative":{"exercise_price":6.72,"exercise_date":"2017-08-11","expiration_date":"2027-08-11","underlying":"Common Stock","underlying_shares":86872},"source":{"system":"sec-edgar","filing":"0001437749-17-014749","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497504/000143774917014749/rdgdoc.xml","form_type":"4"}},{"id":4348636,"issuer":{"id":129056,"kind":"organization","name":"PLx Pharma Inc.","symbol":"PLXP"},"owners":[{"id":71585,"kind":"person","name":"Giordano Natasha","position":1,"cik":"0001315585","reported_name":"Giordano Natasha","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Options","published_at":"2017-04-20T21:15:44.000Z","date":"2017-04-19","kind":"grant","acquired":true,"shares":216580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Received in connection with the Merger in exchange for an employee stock option to buy 275,000 shares of PLx Opco Inc. common stock for $9.80 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is exercisable as to 108,290 shares as of the date hereof, and will become exercisable as to an additional 54,145 shares on each of January 1, 2018 and (subject to continued employment through such date) January 1, 2019."}],"balance_after":216580,"derivative":{"exercise_price":12.44,"expiration_date":"2025-09-25","underlying":"Common Stock","underlying_shares":216580},"source":{"system":"sec-edgar","filing":"0001144204-17-021380","document":"v464778_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1497504/000114420417021380/v464778_4.xml","form_type":"4"}},{"id":4348635,"issuer":{"id":129056,"kind":"organization","name":"PLx Pharma Inc.","symbol":"PLXP"},"owners":[{"id":71585,"kind":"person","name":"Giordano Natasha","position":1,"cik":"0001315585","reported_name":"Giordano Natasha","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-04-20T21:15:44.000Z","date":"2017-04-19","kind":"grant","acquired":true,"shares":1086,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 1,380 shares of common stock of PLx Opco Inc. (formerly PLx Pharma Inc.) in connection with the merger (the \"Merger\") of PLx Opco Inc. with a wholly owned subsidiary of PLx Pharma Inc. (formerly Dipexium Pharmaceuticals, Inc.)."}],"balance_after":1086,"source":{"system":"sec-edgar","filing":"0001144204-17-021380","document":"v464778_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497504/000114420417021380/v464778_4.xml","form_type":"4"}},{"id":4534773,"issuer":{"id":154617,"kind":"organization","name":"ACETO CORP","symbol":"ACETQ"},"owners":[{"id":71585,"kind":"person","name":"Giordano Natasha","position":1,"cik":"0001315585","reported_name":"Giordano Natasha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2016-12-05T08:59:55.000Z","date":"2016-12-01","kind":"grant","acquired":true,"shares":3467,"price":20.19,"value":69998.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock vests 100% after 13 months."}],"balance_after":14235,"source":{"system":"sec-edgar","filing":"0001140361-16-088735","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034/000114036116088735/doc1.xml","form_type":"4"}}]}